Ressource
Clinical Architecture & Performance Reference Manual: Fat Cavitation
CLINICAL ARCHITECTURE & PERFORMANCE REFERENCE MANUAL: FAT CAVITATION
EXECUTIVE SUMMARY
This document provides a comprehensive technical and clinical overview of the Fat Cavitation Aesthetic System, a non-invasive device engineered for the selective reduction of localized adipose tissue. Leveraging the principle of acoustic cavitation, the system generates low-frequency ultrasonic waves that induce the formation and subsequent collapse of microscopic bubbles within the adipocyte cell membrane. This process, known as stable and inertial cavitation, results in the mechanical disruption of the fat cell wall without causing thermal damage to the surrounding dermal and vascular structures. The liberated triglycerides are then metabolized and cleared by the body’s lymphatic system over a period of several weeks. This whitepaper details the device’s clinical architecture, performance specifications, and recommended treatment protocols for medical professionals.

CLINICAL ARCHITECTURE & DESIGN
The Fat Cavitation platform is engineered with a focus on precision, safety, and efficacy. The core of the system is its advanced ultrasonic generator, which produces stable, high-frequency acoustic waves typically in the range of 40 kHz to 70 kHz. This frequency is optimally tuned to maximize the resonant effect on adipocytes while minimizing energy absorption by the dermis, epidermis, and muscle tissue. The energy is delivered through a specialized handpiece equipped with a flat or concave transducer head, designed to focus the ultrasonic beam at a predetermined subcutaneous depth (approximately 10-15mm). This focal point ensures that cavitation occurs precisely within the target adipose layer.
Hardware Topology
1. **Master Control Unit (MCU):** A high-performance microprocessor that regulates frequency, power output, and duty cycle.
2. **Ultrasonic Transducer:** A piezoelectric crystal assembly within the handpiece that converts electrical energy into mechanical vibrations, generating the ultrasonic waves.
3. **Amplifier Module:** A robust Class-D amplifier system ensures high energy conversion efficiency with minimal heat generation, contributing to the device’s stability and longevity.
4. **RF & Therapeutic Synergy (Optional Modules):** The system includes independent interfaces for optional Radio Frequency (RF) or therapeutic ultrasound for enhanced treatment versatility.
5. **User Interface:** An intuitive 15.6-inch high-resolution touchscreen panel provides access to treatment presets, parameter control, and real-time system feedback.
KEY INDICATIONS & CAPABILITIES
This system is specifically indicated for the reduction of localized fat deposits and body contouring of the abdomen, flanks (love handles), thighs, and submental region. It provides a powerful alternative to invasive procedures like liposuction, offering patients a non-surgical option with no downtime. The treatment is most effective for patients with a BMI under 30 who are within 10-15% of their ideal body weight.
– **Target Applications:**
– Reduction of circumference in the abdominal area.
– Smoothing of cellulite appearance (in conjunction with RF).
– Pre-operative and post-operative contouring.
– Treatment of fibrous scar tissue.
– **System Capabilities:**
– **Ultrasound Cavitation:** Adjustable intensity (0.5 – 3.0 W/cm²) to target different tissue depths and patient sensitivities.
– **Cryo Lipolysis (Optional):** Concurrent cooling for enhanced patient comfort and epidermal protection.
– **Multi-Therapy Modes:** Selectable pulsed and continuous wave modes for varying treatment effects.
COMPLIANCE & STANDARDS
The Fat Cavitation device has been developed and manufactured in strict accordance with international medical device standards and regulatory requirements. The system is CE marked (Class IIa) and has undergone rigorous testing for electrical safety, electromagnetic compatibility, and biological compatibility.
– **Safety Certifications:**
– Medical Electrical Equipment: IEC 60601-1, IEC 60601-2-6, IEC 60601-1-2 (EMC).
– Laser/Acoustic Safety: Compliant with 21 CFR 1040 for FDA requirements.
– **Regulatory Status:**
– The device is intended for use by licensed healthcare professionals in clinics, medical spas, and dermatology practices. All clinical protocols should be conducted following a thorough patient consultation and medical history review.
TECHNICAL SPECIFICATIONS
| Parameter | Specification |
|---|---|
| Ultrasonic Frequency | 40 kHz ± 5% (Selectable up to 70 kHz) |
| Output Intensity | 0.5 – 3.0 W/cm² (Adjustable in 0.1 W increments) |
| Operating Mode | Continuous / Pulsed (1-10 Hz) |
| Treatment Depth | 10-15 mm (Focused at 15 mm) |
| Handpiece Type | Ergonomic, Lightweight (approx. 250g) |
| Display | 15.6″ Color TFT LCD Touchscreen |
| Power Supply | AC 110-240V, 50/60Hz |
| Power Consumption | Max 450W |
| Cooling System | Air-Cooled (Internal Fans) + Optional Saphire Tip |
CLINICAL PROTOCOLS
To achieve optimal clinical outcomes, strict adherence to the following protocols is recommended:
– **Pre-Treatment:**
– Patient consultation to set expectations and review contraindications.
– Marking of the treatment area with a surgical skin marker.
– Application of a medical-grade ultrasound gel as a coupling agent to ensure efficient energy transmission.
– **During Treatment:**
– Settings: Begin with lower intensities (e.g., 1.0 W/cm²) and increase as patient comfort permits.
– Technique: Utilize slow, circular or linear strokes over the marked area to ensure uniform energy delivery. Each treatment session for a single area should not exceed 20-30 minutes.
– Patient Feedback: Maintain continuous verbal communication with the patient to monitor for any discomfort.
– **Post-Treatment:**
– Remove gel and cleanse the area.
– Recommend increased water intake (2-3 liters) for 72 hours post-treatment to facilitate lymphatic clearance.
– Encourage light exercise to boost metabolic rate.
– A typical treatment course consists of 6-8 sessions, spaced 3-7 days apart. Results are progressive and become visible approximately 2-4 weeks after the final session.

DISCLAIMER: The information contained in this datasheet is for educational and informational purposes only and should not be construed as a substitute for professional medical advice. The device should be used by trained personnel only.
📥 Download Technical Specification
Click the button below to view or download the full official PDF datasheet.